Burzynski: Managing social conflict in complementary and alternative medicine research: the case of antineoplastons

3/2004 – antineoplastons – A10 and AS2-1
http://www.ncbi.nlm.nih.gov/m/pubmed/15035877
From 12/1991 – 12/1995 phase II clinical trials were conducted

This publication covers the issues involved

National Cancer Institute (NCI)

National Institutes of Health Office of Alternative Medicine (OAM)

International Peace and Conflict Resolution Program, School of International Service, American University, Washington, DC, USA
Integr Cancer Ther. 2004 Mar;3(1):59-65
Integr Cancer Ther 3(1):59-65 (2004)
Integrative Cancer Therapies
HighWire Press
DOI:10.1177/1534735404263448

Advertisements